The Short Report

TARS
Tarsus Pharmaceuticals, Inc.

1 report on Tarsus Pharmaceuticals, Inc. (TARS) by Culper Research, summarized: the thesis, evidence and key numbers. Latest: Oct 27, 2026.

No spam. Unsubscribe anytime.

All Reports TARS × / Market Intelligence

TARS

1 of 1 reports
TARS —
—
TARS Tarsus Pharmaceuticals, Inc.

Tarsus Pharmaceuticals (TARS): Short Report – Culper Research

Culper Research alleges Tarsus's XDEMVY growth relies on Healthwell copay funding, pharmacy steering, and a much smaller market.

Culper Research
Oct 27, 2026